Succinate prodrug, compositions containing the succinate prodrug and uses thereof
AssigneeAbliva AB
InventorsMagnus Joakim Hansson, Alvar Grönberg, Mats Eskil Elmér, Mark Richard Farmery, Steven James Moss, Lee Robert Webster, Matthew Alan Gregory
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel isolated succinate prodrug as the free compound or a salt, hydrate, solvate or complex thereof being cell permeable and aimed for increasing the ATP-production in mitochondria. The compound is useful in the medical treatment of a range of diseases, in nutritional supplements, nutricosmetics and in cosmetics.
Claims14
Isolated Methyl 3-[(2-acetylaminoethylthio) carbonyl]propionate (Compound 1) in solid form, having a purity of at least 80% w/w, at least 90% w/w, at least 95% w/w, at least 97% w/w, at least 98% w/w or at least 99% w/w.
Dependencies are inferred from the claim text.